- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Medicamen Biotech Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting
14-08-2026 | 03:39 pm
14-08-2026 | 03:39 pm
Medicamen Biotech's board approved Q1 consolidated revenue of ₹48.76 Cr and net profit of ₹1.85 Cr. They also proposed a final dividend of Re. 1 (10%) per share, subject to shareholder approval at the 33rd AGM on Sept 26, 2026.
No comments yet. Be the first to comment!